Literature DB >> 30209699

The performance of patients with Parkinson's disease on the Face-Name Associative Memory Examination.

Constantinos Kormas1, Ioannis Zalonis2, Ioannis Evdokimidis2, Constantin Potagas2.   

Abstract

In this study, we examined the performance of patients with Parkinson's disease (PD) with different cognitive profiles on the Face-Name Associative Memory Examination (FNAME). We evaluated 71 patients with a comprehensive neuropsychological battery. The results revealed that the group with executive and additional visuospatial deficits demonstrated significantly lower scores on FNAME. This finding indicates the possible clinical utility of FNAME for screening patients with PD with distinct cognitive profiles. Further longitudinal studies are needed to consider the prognostic adequacy of FNAME in detecting high-risk Parkinson's disease dementia (PDD).

Entities:  

Keywords:  Cognitive impairment; Executive functions; Face-Name Associative Memory Examination; Parkinson’s disease; Visuospatial functions

Mesh:

Year:  2018        PMID: 30209699     DOI: 10.1007/s10072-018-3560-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  14 in total

1.  A normative study of the trail making test A and B in Greek adults.

Authors:  I Zalonis; E Kararizou; N I Triantafyllou; E Kapaki; S Papageorgiou; P Sgouropoulos; D Vassilopoulos
Journal:  Clin Neuropsychol       Date:  2007-11-01       Impact factor: 3.535

2.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

3.  Face-name associative memory performance is related to amyloid burden in normal elderly.

Authors:  Dorene M Rentz; Rebecca E Amariglio; J Alex Becker; Meghan Frey; Lauren E Olson; Katherine Frishe; Jeremy Carmasin; Jacqueline E Maye; Keith A Johnson; Reisa A Sperling
Journal:  Neuropsychologia       Date:  2011-06-12       Impact factor: 3.139

4.  Normative Data of the Montreal Cognitive Assessment in the Greek Population and Parkinsonian Dementia.

Authors:  K Konstantopoulos; P Vogazianos; T Doskas
Journal:  Arch Clin Neuropsychol       Date:  2016-02-17       Impact factor: 2.813

Review 5.  Cognitive impairment and dementia in Parkinson's disease.

Authors:  Javier Pagonabarraga; Jaime Kulisevsky
Journal:  Neurobiol Dis       Date:  2012-03-30       Impact factor: 5.996

6.  Neuropathologic substrates of Parkinson disease dementia.

Authors:  David J Irwin; Matthew T White; Jon B Toledo; Sharon X Xie; John L Robinson; Vivianna Van Deerlin; Virginia M-Y Lee; James B Leverenz; Thomas J Montine; John E Duda; Howard I Hurtig; John Q Trojanowski
Journal:  Ann Neurol       Date:  2012-10-04       Impact factor: 10.422

7.  Development of the Greek version of the Face Name Associative Memory Exam (GR-FNAME12) in cognitively normal elderly individuals.

Authors:  Constantinos Kormas; Anastasia Megalokonomou; Ioannis Zalonis; Ioannis Evdokimidis; Elisabeth Kapaki; Constantin Potagas
Journal:  Clin Neuropsychol       Date:  2018-07-02       Impact factor: 3.535

8.  The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline.

Authors:  Angela Sanabria; Montserrat Alegret; Octavio Rodriguez-Gomez; Sergi Valero; Oscar Sotolongo-Grau; Gemma Monté-Rubio; Carla Abdelnour; Ana Espinosa; Gemma Ortega; Alba Perez-Cordon; Anna Gailhajanet; Isabel Hernandez; Maitee Rosende-Roca; Liliana Vargas; Ana Mauleon; Domingo Sanchez; Elvira Martin; Dorene M Rentz; Francisco Lomeña; Agustin Ruiz; Lluis Tarraga; Merce Boada
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

Review 9.  Cognitive decline in Parkinson's disease: the complex picture.

Authors:  Roberta Biundo; Luca Weis; Angelo Antonini
Journal:  NPJ Parkinsons Dis       Date:  2016-09-01

Review 10.  Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis.

Authors:  Angie A Kehagia; Roger A Barker; Trevor W Robbins
Journal:  Neurodegener Dis       Date:  2012-10-03       Impact factor: 2.977

View more
  1 in total

1.  The Modality Effect on Delayed Free Recall in Non-demented Patients With Mild Parkinson's Disease Progression.

Authors:  Constantinos Kormas; Ioannis Zalonis; Ioannis Evdokimidis; Elisabeth Kapaki; Constantin Potagas
Journal:  Front Aging Neurosci       Date:  2019-07-23       Impact factor: 5.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.